Wikidata

(Q73942932)

English

Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial.

scientific article published on 01 July 2000

In more languages

Statements

title
Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial. The European Orgalutran Study Group (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
10875855
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10875855%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 November 2019

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q73942932&oldid=1221875924"